|
|
pigmentation
|
GO:0043473 |
71 |
0.986
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.961
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.943
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.930
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.927
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.898
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.841
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.823
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.798
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.796
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.788
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.740
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.740
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.734
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.720
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.716
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.680
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.679
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.677
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.666
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.657
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.651
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.643
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.639
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.635
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.623
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.616
|
|
|
|
trachea gland development
|
GO:0061153 |
3 |
0.615
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.614
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.611
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.589
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.584
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.573
|
|
|
|
positive regulation of protein kinase a signaling
|
GO:0010739 |
2 |
0.569
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.565
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.565
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.562
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.555
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.551
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.547
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.547
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.544
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.540
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.539
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.524
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.515
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.502
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.474
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.472
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.469
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.466
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.459
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.454
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.454
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.449
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.438
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.432
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.431
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.430
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.428
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.426
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.424
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.422
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.420
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.419
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.412
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.411
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.402
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.400
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.394
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.391
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.385
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.384
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.383
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.382
|
|
|
|
regulation of corticosterone secretion
|
GO:2000852 |
2 |
0.382
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.381
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.378
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.377
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.373
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.370
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.368
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.366
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.366
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.362
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.357
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.356
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.355
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.355
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.353
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.350
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.342
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.338
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.337
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.331
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.330
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.327
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.323
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.314
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.314
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.311
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.309
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.305
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.305
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.303
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.302
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.301
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.301
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.298
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.298
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.295
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.292
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.291
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.289
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.287
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.284
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.280
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.277
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.272
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.271
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.270
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.262
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.260
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.256
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.255
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.248
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.245
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.243
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.242
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.238
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.236
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.236
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.235
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.230
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.227
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.225
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.222
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.222
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.221
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.220
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.219
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.215
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.212
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.212
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.211
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.210
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.209
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.208
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.208
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.206
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.203
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.203
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.203
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.202
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.202
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.198
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.197
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.195
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.194
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.187
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.185
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.184
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.184
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.183
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.182
|
|
|
|
metanephric nephron tubule morphogenesis
|
GO:0072282 |
7 |
0.181
|
|
|
|
regulation of glucocorticoid secretion
|
GO:2000849 |
5 |
0.181
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.180
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.179
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.176
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.174
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.173
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.173
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
5 |
0.172
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.170
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.169
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.169
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.168
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.168
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.167
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.167
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.158
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.158
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.158
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.157
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.156
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.154
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.153
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.153
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.152
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.151
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.150
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.149
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.147
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.147
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.147
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.143
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.143
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.142
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.141
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.141
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.140
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.140
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.139
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.138
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.138
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.138
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.137
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.133
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.131
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.130
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.130
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.129
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.129
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.128
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.128
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.126
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.124
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.124
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.123
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.122
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.122
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.122
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.121
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.121
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.119
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.119
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.119
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.119
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.118
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.117
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.116
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.116
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.115
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.115
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.114
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.114
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.113
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.113
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.111
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.111
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.111
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.110
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.109
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.109
|
|
|
|
mesenchymal cell apoptotic process
|
GO:0097152 |
14 |
0.108
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.107
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.107
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.106
|
|
|
|
steroid hormone secretion
|
GO:0035929 |
9 |
0.105
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.104
|
|
|
|
regulation of corticosteroid hormone secretion
|
GO:2000846 |
5 |
0.104
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.103
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.103
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.103
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.102
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.102
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.102
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.101
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.101
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.100
|
|
|
|
ureter morphogenesis
|
GO:0072197 |
4 |
0.100
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.100
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.098
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.098
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.098
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.098
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.097
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.095
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.095
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.095
|
|
|
|
salivary gland cavitation
|
GO:0060662 |
5 |
0.094
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.094
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.093
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.092
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.091
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.090
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.090
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.090
|
|
|
|
positive regulation of extracellular matrix organization
|
GO:1903055 |
4 |
0.089
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.089
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.087
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.087
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.087
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.087
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.087
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.087
|
|
|
|
positive regulation of protein kinase c signaling
|
GO:0090037 |
1 |
0.087
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.086
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.086
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.086
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.085
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.085
|
|
|
|
mammary gland bud morphogenesis
|
GO:0060648 |
4 |
0.085
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.085
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.084
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.084
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.084
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.084
|
Human |
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.083
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.083
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.083
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.083
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.082
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.082
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.082
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.081
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.081
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.081
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.081
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.081
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.080
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.080
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.080
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.080
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.079
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.079
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.078
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.077
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.077
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.076
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.076
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.076
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.076
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.075
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.075
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.074
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.074
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.074
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.074
|
|
|
|
melanin biosynthetic process
|
GO:0042438 |
10 |
0.074
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.074
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.073
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.073
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.073
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.073
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.072
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.072
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.071
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.071
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.071
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.071
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.071
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.071
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.070
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.070
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.070
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.070
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.069
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.069
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.069
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.069
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.069
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification
|
GO:0021913 |
4 |
0.069
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.069
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.068
|
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.068
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.067
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.067
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.067
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.066
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.066
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.065
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.065
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.065
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.065
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.065
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.065
|
|
|
|
regulation of mesodermal cell fate specification
|
GO:0042661 |
5 |
0.065
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.064
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.063
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.063
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.062
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.062
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.062
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.062
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.062
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.062
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.062
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.061
|
|
|
|
trachea development
|
GO:0060438 |
18 |
0.061
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.061
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.061
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.061
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.061
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.060
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.060
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.060
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.060
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.060
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.059
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.059
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.059
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.058
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.058
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.058
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.057
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.057
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.056
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.056
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.056
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.055
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.055
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.054
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.054
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.054
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.053
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.053
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.053
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.053
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.053
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.053
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.052
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.051
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.051
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.051
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.050
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.050
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.050
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.050
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.050
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.050
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.050
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.050
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.050
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.050
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.050
|
|
|
|
endocardium formation
|
GO:0060214 |
4 |
0.050
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.049
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.049
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.049
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.049
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.049
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.049
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.048
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.048
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.048
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.048
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.047
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.047
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.047
|
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.047
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.047
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.047
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.047
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.047
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.047
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.046
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.046
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.046
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.046
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.045
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.045
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.045
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.045
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.045
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.045
|
|
|
|
secondary metabolite biosynthetic process
|
GO:0044550 |
11 |
0.045
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.044
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.044
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.044
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.044
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.044
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.044
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.044
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.044
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.044
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.044
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.044
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.043
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.043
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.043
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.042
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.042
|
|
|
|
positive regulation of chondrocyte differentiation
|
GO:0032332 |
13 |
0.042
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.042
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.042
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.042
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.042
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.041
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.041
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.041
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.041
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.041
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.041
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.041
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.041
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.041
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.041
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.041
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.040
|
|
